Suppr超能文献

α-1抗胰蛋白酶缺乏症所致肺病的性别差异——来自德国登记处的分析

Sex differences in alpha-1-antitrypsin deficiency lung disease-analysis from the German registry.

作者信息

Fähndrich Sebastian, Herr Christian, Greulich Timm, Seibert Martina, Lepper Philipp M, Bernhard Nikolas, Lützow Cindy, Vogelmeier Claus, Bals Robert

机构信息

1Department of Internal Medicine V - Pulmonology, Allergology, Intensive Care Medicine, Saarland University Hospital , Homburg , Germany.

出版信息

COPD. 2015 May;12 Suppl 1:58-62. doi: 10.3109/15412555.2015.1023785.

Abstract

Alpha-1-antitrypsin deficiency (AATD) is a rare condition with clinical manifestations of the lung and the liver. There is evidence that the gender affects the clinical presentation of non-AATD chronic obstructive lung disease (COPD). The aim of this study was to analyze gender-dependent disease pattern in AATD-based COPD. Data from 1066 individuals from the German AATD registry were analyzed by descriptive and analytical statistics. The AAT genotypes comprised 820 individuals with PiZZ (male 56%, female 45%), 109 with PI SZ (male 55%; female 45%), and others (n = 137). A subgroup of 422 patients with available post-bronchodilator FEV1% predicted was analyzed in detail after stratification in spirometric GOLD stages I-IV. The age of the registered individuals is 52.2 ± 13.4 years (male: 51.91 ± 13.86 years; female: 52.76 ± 13.39 years). Female patients with GOLD I-IV showed lower numbers of pack-years and lower BMI. The time between the first symptom and the establishment of the correct diagnosis was significantly longer in female (14.47 ± 16.46 years) as compared to male individuals (12.39 ± - 14.38 years, p = 0.04). In conclusion, the data of the registry allow to characterize the natural course of the disease and highlight differences in the clinical presentation of patients with AATD-dependent COPD.

摘要

α-1抗胰蛋白酶缺乏症(AATD)是一种罕见疾病,具有肺部和肝脏的临床表现。有证据表明,性别会影响非AATD慢性阻塞性肺疾病(COPD)的临床表现。本研究的目的是分析基于AATD的COPD中与性别相关的疾病模式。通过描述性和分析性统计分析了来自德国AATD登记处的1066名个体的数据。AAT基因型包括820名PiZZ个体(男性56%,女性45%)、109名PI SZ个体(男性55%;女性45%)以及其他个体(n = 137)。在根据肺功能GOLD分级I-IV分层后,对422例有可用支气管扩张剂后FEV1%预测值的患者亚组进行了详细分析。登记个体的年龄为52.2±(13.4)岁(男性:51.91±(13.86)岁;女性:52.76±(13.39)岁)。GOLD I-IV级的女性患者吸烟包年数和体重指数较低。与男性个体(12.39±(14.38)年,p = 0.04)相比,女性从出现首个症状到确诊的时间明显更长(14.47±(16.46)年)。总之,登记处的数据有助于描述该疾病的自然病程,并突出AATD相关性COPD患者临床表现的差异。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验